(非常重要)國外有病例,狗植入晶片會產生惡性腫瘤!!

國外有病例狗植入晶片會產生惡性腫瘤!!

台北市法律規定要植入晶片只是為流浪狗. 但是沒有任何獸醫去說明以前的病例~~~ 難怪有日本獸醫說他不為自己的狗植入晶片了
以下為日文,我懶得翻譯了(雖然我每一字都懂)

(全文)
http://ameblo.jp/ganbarumei/entry-10101393792.html

確かな文献で犬にマイクロチップで腫瘍が発生した症例報告（2006.6月）が

ありましたので詳しく載せておきます。
--------------------------------------------------------------------------------------


「9歳オスのフレンチブルドックのマイクロチップ埋没部位に位置する

皮下マスを検査した。マスの細胞診は、悪性間葉系腫瘍を示唆するものだった。

組織学的にそのマスは、多病巣壊死と末梢リンパ凝集を伴う高グレード浸潤性

線維肉腫と確認された。免疫組織化学検査で、ビメンチン、平滑筋アクチン（SMA）、

CD3、CD79アルファ、CD18を調査した。全ての腫瘍細胞はビメンチン陽性だった。

病変末梢の散見細胞も筋線維芽細胞表現型を強調するSMA陽性だった。

リンパ球はCD18、CD3に陽性だった。オーリントリカルボン酸法によりアルミニウム

沈着は検出されなかった。猫の注射後肉腫に形態学的に類似する線維肉腫の

診断がなされた。注射部位の線維肉腫はイヌやフェレットで報告されている。

さらに犬と実験げっ歯類で、マイクロチップ埋没部位に腫瘍の成長が述べられている。(St訳)」



-------------------------------------------------------------------------------------------
この症例報告は2年前の話です。

http://www.thedogplace.org/Articles/DogCare/0705.No.Microchip.RDOWS.htm

Medical Reasons NOT to Microchip

RDOWS POSITION STATEMENT ON MANDATORY MICROCHIPPING

Responsible Dog Owners of the Western States opposes any mandated microchipping of privately held domestic pet animals. The choice of whether to or whether not to microchip should be based upon all available information; and left strictly up to the owner to make for his/her animals. Our research has discovered potential health risks that are posed to domestic pet animals from microchip emplacement. Due to space only two of several findings will be cited:

(1) Vet Pathology 43:545-548 (2006) (c) 2006 American College of Veterinary Pathologists.

Fibrosarcoma with Typical Features of Postinjection Sarcoma at Site of Microchip Implant in a Dog: Histologic and Immunohistochemical Study - M. Vascellari, E. Melchiotti and F. Mutinelli Abstract

A 9-year-old, male French Bulldog was examined for a subcutaneous mass located at the site of a microchip implant. Cytologic examination of the mass was suggestive of a malignant mesenchymal neoplasm. Histologically, the mass was confirmed as a high-grade infiltrative fibrosarcoma, with multifocal necrosis and peripheral lymphoid aggregates. By immunohistochemistry, the sample was investigated for vimentin, smooth-muscle actin (SMA), CD3, CD79, and CD18.

All the neoplastic cells were positive for vimentin. Scattered cells at the periphery of the lesion were also positive for SMA, highlighting a myofibroblastic phenotype. The lymphoid cells were positive for CD18 and CD3. No aluminum deposits were detected by the aurintricarboxylic acid method. A diagnosis of fibrosarcoma morphologically similar to feline post injection sarcomas was made. Fibrosarcomas at the site of injections have been reported in dogs and ferrets. Furthermore, neoplastic growth at the site of microchip implant in dog and laboratory rodents has been described.

Key words: Dog; fibrosarcoma; immunohistochemistry; microchip.
Marta Vascellari, Istituto Zooprofilattico Sperimentale delle Venezie, Viale dell'Università 10, 35020 Legnaro (PD) (Italy).

(2) Tumors in long-term rat studies associated with microchip animal identification devices.

Tumors surrounding implanted microchip animal identification devices were noted in two separate chronic toxicity/oncogenicity studies using F344 rats. The tumors occurred at a low incidence rate (approximately 1 percent), but did result in the early sacrifice of most affected animals, due to tumor size and occasional metastases. No sex-related trends were noted. All tumors occurred during the second year of the studies, were located in the subcutaneous dorsal thoracic area (the site of microchip implantation) and contained embedded microchip devices. All were mesenchymal in origin and consisted of the following types, listed in order of frequency: malignant schwannoma, fibrosarcoma, anaplastic sarcoma, and histiocytic sarcoma. The following diagnostic techniques were employed: light microscopy, scanning electron microscopy, and immunohistochemistry. The mechanism of carcinogenicity appeared to be that of foreign-body induced tumorigenesis.

Centre national de la recherche scientifique (21/09/2000) 2001, vol. 52, no 6, pp. 569-575 (24 ref.), pp. 483-491

Responsible Dog Owners of the Western States (RDOWS)
Cherie Graves, chairwoman, paragon@surf1.ws
Hermine Stover hermine@endangeredspecies.com
--------------------------------------------------------------------------------------

狗晶片問市不夠久,等到狗老了之後才有可能發生癌症
再等普及個20年確定沒問題再說吧~(除非狗要出國~~發生機率高嗎?)

建議台北市政府強制飼主掛有登記的狗牌,而不是強制植入晶片(你是怕狗牌會掉or棄養嗎? )

人都不敢植入晶片,為什麼狗要植晶片?? (下面隨便找的)
己所不欲 勿施於"狗" ~~~~

--------------------------------------------------------------------------------------


http://big5.lrn.cn/science/scienceNews/200804/t20080408_216653.htm

“人體晶片”早已面世

　　真正將類似“異想天開”想法落在實地的公司，是美國數字應用解決方案公司Applied　Digital　Solutions(以下簡稱ADS)，該公司突破重重阻力開發成功的“VeriChip”晶片已經面市多年。

　　2002年10月，一種名為“VeriChip”的晶片突然在美國市場上銷售。它只比一粒米大一點，一開始只用於動物。2004年10月該產品獲得美國食品與藥品監督管理局批准用於人體。

　　簡直是必然的，消息一公佈就在宗教和人權團體裏炸開了鍋。人們不停地問，“這真的可以銷售嗎？”ADS公司一邊向憤怒的人們解釋，一邊大張旗鼓地宣傳促銷。他們將數輛大型巴士改裝成貼滿廣告的“ChipMobile”專用汽車，以美國南部為中心進行宣傳遊行。汽車上裝有大批VeriChip，遊說人們植入這種新奇的晶片。

　　每個VeriChip裏記錄一組獨一無二的識別碼，利用特定頻率的掃描器，平時處於休眠狀態的VeriChipp會被激活，發出無線電信號，進行身份確認。換句話說，只要將它植入你的皮下，不管是用金融卡提款，還是用信用卡消費，只需在現場讓刷卡機“刷自己”，取得VeriChip的識別碼後，就能完成交易。被人盜刷信用卡的事再也不會發生了。

　　這種人體晶片普及得並沒有想像中快，有業內人士認為，晶片本身“已經開發的功能”不多是原因之一，人們需要極強的“誘惑”，才願意充當第一批吃螃蟹的人。畢竟，這是在拿生命開玩笑。

　　很多敵視“人體晶片”的人，一直以來就認定這確實是在“玩命”，他們的證據是2007年9月美聯社的一篇恐怖報道。該報道稱，VeriChip晶片發射器可導致實驗老鼠產生惡性腫瘤。美聯社的報道採用了部分人權保護組織人士的評論。雖然文章存在漏洞，且為ADS公司的反擊留下把柄，但壞影響已經造成，ADS公司的股價在消息發佈後一瀉千里。隨後ADS公司聲明，已經接受“晶片植入”的動物總數超過百萬，並沒有導致腫瘤。儘管如此，該公司用於舉例的上萬條魚、上千條貓和狗，仍然不能讓惶惶不安的人們鎮靜下來。該公司2007年的數據顯示，經過幾年的不懈遊說，只有2000人進行了晶片植入試驗。

--------------------------------------------------------------------------------------
補充資料

(中文)
http://www28.discuss.com.hk/redirect.php?fid=430&tid=6960104&goto=nextoldset

(英文)
http://www.washingtonpost.com/wp-dyn/content/article/2007/09/08/AR2007090800997_pf.html
http://www.antichips.com/cancer/index.html
http://www.nakedcapitalism.com/2007/09/microchip-implants-may-cause-cancer.html
http://blog.wired.com/sterling/2007/11/arphid-watch-al.html


以上文章只供意見參考之用